{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:54:09Z","timestamp":1791600849033,"version":"4.3.4"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is a lack of comprehensive, large cohort studies investigating the predictors for severity and hospitalization in human granulocytic anaplasmosis (HGA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study including all cases of HGA identified by positive blood Anaplasma polymerase chain reaction (PCR) at the Mayo Clinic Laboratory, Rochester between 2011 and 2021. Multivariable logistic regression was performed to evaluate risk factors associated with hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 465 cases were identified. Of those, 67% (n = 312) were managed in the outpatient setting. Hospitalized patients (n = 153, 33%) were more likely to be older (median age of 71 vs 61; P \u2264 .001) and immunocompromised (17% vs 7%; P \u2264 .001). The triad of leukopenia, thrombocytopenia, and transaminitis was observed in 24% of the cases, but was associated with risk of hospitalization (odds ratio [OR] 1.78, 95% confidence interval [CI]: 1.05\u20133.03; P \u2264 .033). The presence of a coinfection did not impact mortality or hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The risk factors for hospitalization in patients with HGA include altered mental status, higher absolute neutrophil count (ANC), advanced age, comorbidities, and immunosuppression. The classic hematological and biochemical profile may be absent in the majority of cases. Co-testing may be of higher benefit in select cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf171","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T07:47:46Z","timestamp":1743493666000},"page":"539-547","source":"Crossref","is-referenced-by-count":7,"title":["Trends in Anaplasmosis Over the Past Decade: A Review of Clinical Features, Laboratory Data, and Outcomes"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2065-2586","authenticated-orcid":false,"given":"Silpita","family":"Katragadda","sequence":"first","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, College of Medicine and Science, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2098-2868","authenticated-orcid":false,"given":"Zachary A","family":"Yetmar","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Integrated Hospital-Care Institute, Cleveland Clinic Foundation , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3507-6411","authenticated-orcid":false,"given":"Supavit","family":"Chesdachai","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, College of Medicine and Science, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3630-0668","authenticated-orcid":false,"given":"Madiha","family":"Fida","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, College of Medicine and Science, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0261-1326","authenticated-orcid":false,"given":"Bobbi S","family":"Pritt","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, College of Medicine and Science, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]},{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-9639","authenticated-orcid":false,"given":"Douglas W","family":"Challener","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, College of Medicine and Science, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar M","family":"Abu Saleh","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, College of Medicine and Science, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9538-6214","authenticated-orcid":false,"given":"Nischal","family":"Ranganath","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, College of Medicine and Science, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]},{"name":"Division of Hospital Internal Medicine, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"2026051307430821500_ciaf171-B1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1196\/annals.1355.069","article-title":"Anaplasma and Ehrlichia infection","volume":"1063","author":"Dumler","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"2026051307430821500_ciaf171-B2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1089\/vbz.2019.2598","article-title":"Increasing incidence of anaplasmosis in the United States","author":"Baker","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"suppl 1","key":"2026051307430821500_ciaf171-B3","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1086\/518146","article-title":"Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment","volume":"45","author":"Dumler","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026051307430821500_ciaf171-B4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.mayocp.2011.09.008","article-title":"Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts","volume":"87","author":"Weil","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"2026051307430821500_ciaf171-B5","doi-asserted-by":"crossref","first-page":"ofad193","DOI":"10.1093\/ofid\/ofad193","article-title":"Anaplasmosis in Pennsylvania: clinical features, diagnosis, and outcomes of patients diagnosed with Anaplasma phagocytophilum infection at Hershey Medical Center from 2008 to 2021","volume":"10","author":"Ingram","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026051307430821500_ciaf171-B6","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3201\/eid2110.150143","article-title":"Human infection with Ehrlichia muris\u2013like pathogen, United States, 2007\u20132013","volume":"21","author":"Johnson","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2026051307430821500_ciaf171-B7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.idc.2015.02.007","article-title":"Human granulocytic anaplasmosis","volume":"29","author":"Bakken","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"2026051307430821500_ciaf171-B8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1086\/313948","article-title":"Human granulocytic ehrlichiosis","volume":"31","author":"Bakken","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2026051307430821500_ciaf171-B9","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/515048","article-title":"Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin","volume":"27","author":"Bakken","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2026051307430821500_ciaf171-B10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13071-016-1529-y","article-title":"Human pathogens associated with the blacklegged tick Ixodes scapularis: a systematic review","volume":"9","author":"Nelder","year":"2016","journal-title":"Parasites Vectors"},{"key":"2026051307430821500_ciaf171-B11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4269\/ajtmh.2005.73.400","article-title":"Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001\u20132002","volume":"73","author":"Demma","year":"2005","journal-title":"Am J Trop Med Hyg."},{"key":"2026051307430821500_ciaf171-B12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.idc.2022.02.008","article-title":"Human granulocytic anaplasmosis","volume":"36","author":"MacQueen","year":"2022","journal-title":"Infect Dis Clin North Am"},{"key":"2026051307430821500_ciaf171-B13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/319350","article-title":"Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis","volume":"32","author":"Bakken","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2026051307430821500_ciaf171-B14","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/microorganisms10071433","article-title":"Human granulocytic anaplasmosis\u2014a systematic review of published cases","volume":"10","author":"Dumic","year":"2022","journal-title":"Microorganisms"},{"key":"2026051307430821500_ciaf171-B15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/cid\/cis852","article-title":"Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity","volume":"56","author":"Horowitz","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2026051307430821500_ciaf171-B16","doi-asserted-by":"crossref","first-page":"101648","DOI":"10.1016\/j.tmaid.2020.101648","article-title":"Assessment of Anaplasma phagocytophilum presence in early Lyme borreliosis manifested by Erythema migrans skin lesions","volume":"36","author":"Moniuszko-Malinowska","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"2026051307430821500_ciaf171-B17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1086\/339813","article-title":"Disease-specific diagnosis of coinfecting tickborne zoonoses; babesiosis, human granulocytic ehrlichiosis, and Lyme disease","volume":"34","author":"Krause","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2026051307430821500_ciaf171-B18","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/368187","article-title":"Prospective study of coinfection in patients with Erythema migrans","volume":"36","author":"Steere","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2026051307430821500_ciaf171-B19","first-page":"1","article-title":"Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis\u2014United States: a practical guide for physicians and other health-care and public health professionals","volume":"55","author":"Chapman","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"2026051307430821500_ciaf171-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6502a1","article-title":"Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis\u2014United States","volume":"65","author":"Biggs","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"2026051307430821500_ciaf171-B21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4269\/ajtmh.15-0122","article-title":"Human granulocytic anaplasmosis in the United States from 2008 to 2012: a summary of national surveillance data","volume":"93","author":"Dahlgren","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"2026051307430821500_ciaf171-B22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1525-1497.2005.00218.x","article-title":"Human granulocytic anaplasmosis affecting the myocardium","volume":"20","author":"Malik","year":"2005","journal-title":"J Gen Intern Med"},{"key":"2026051307430821500_ciaf171-B23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/jgid.jgid_116_16","article-title":"Hemophagocytic lymphohistiocytosis associated with anaplasmosis","volume":"9","author":"Johnson","year":"2017","journal-title":"J Glob Infect Dis"},{"key":"2026051307430821500_ciaf171-B24","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1468-1331.2006.01582.x","article-title":"Encephalopathy with seizures having PCR-positive Anaplasma phagocytophilum and Ehrlichia chaffeensis","volume":"14","author":"Young","year":"2007","journal-title":"Eur J Neurol"},{"key":"2026051307430821500_ciaf171-B25","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3390\/microorganisms11061483","article-title":"Anaplasma phagocytophilum community-acquired pneumonia: case report and literature review","volume":"11","author":"Dumic","year":"2023","journal-title":"Microorganisms"},{"key":"2026051307430821500_ciaf171-B26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12879-018-3321-4","article-title":"Manifestation of anaplasmosis as cerebral infarction: a case report","volume":"18","author":"Kim","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2026051307430821500_ciaf171-B27","doi-asserted-by":"crossref","first-page":"e13129","DOI":"10.1111\/tid.13129","article-title":"Anaplasma phagocytophilum presenting with orchitis in a renal transplant recipient","volume":"21","author":"Khatri","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"2026051307430821500_ciaf171-B28","doi-asserted-by":"crossref","first-page":"1543.e1","DOI":"10.1016\/j.ajem.2020.03.066","article-title":"Rare case of severe rhabdomyolysis secondary to human granulocytic anaplasmosis","volume":"38","author":"Jawanda","year":"2020","journal-title":"Am J Emerg Med"},{"key":"2026051307430821500_ciaf171-B29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0025-6196(11)61006-9","article-title":"Rhabdomyolysis and acute renal failure associated with human granulocytic anaplasmosis","volume":"82","author":"Boateng","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"2026051307430821500_ciaf171-B30","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJMcpc059004","article-title":"Case records of the Massachusetts General Hospital. Case 10\u20132005. A 73-year-old man with weakness and pain in the legs","volume":"352","author":"Heller","year":"2005","journal-title":"N Engl J Med"},{"key":"2026051307430821500_ciaf171-B31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1574-695X.2011.00909.x","article-title":"The biological basis of severe outcomes in Anaplasma phagocytophilum infection","volume":"64","author":"Dumler","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2026051307430821500_ciaf171-B32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1086\/517678","article-title":"Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin","volume":"27","author":"Buitrago","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2026051307430821500_ciaf171-B33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/AAC.47.1.413-415.2003","article-title":"Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States","volume":"47","author":"Maurin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2026051307430821500_ciaf171-B34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1089\/vbz.2006.6.388","article-title":"Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis","volume":"6","author":"Wormser","year":"2006","journal-title":"Vector Borne Zoonotic Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf171\/62846623\/ciaf171.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/3\/539\/62846623\/ciaf171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/3\/539\/62846623\/ciaf171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:16:55Z","timestamp":1778674615000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/3\/539\/8104456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,4,3]]},"published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf171","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,15]]},"published":{"date-parts":[[2025,4,3]]}}}